Stock VERA VERA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Vera Therapeutics, Inc.

Equities

VERA

US92337R1014

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
42.33 USD -5.81% Intraday chart for Vera Therapeutics, Inc. -2.69% +175.23%
May. 09 Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GL
Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K
PU
Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge
DJ
Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition
DJ
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
GL
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
AQ
Certain Restricted Stock Units of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
CI
Certain Stock Options of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
CI
Certain Class A common stock of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
CI
Wedbush Raises Vera Therapeutics' Price Target to $34 From $21 After Model Update, Maintains Neutral rating
MT
Sector Update: Health Care Stocks Steady Premarket Wednesday
MT
Vera Therapeutics' 2023 Loss Narrows
MT
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Vera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Developing a new treatment paradigm for IgAN
AQ
Certain Restricted Stock Units of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 14-MAR-2024.
CI
Certain Stock Options of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 14-MAR-2024.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VERA Stock
  4. News Vera Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW